PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26463665-7	2015	The TNF-mediated chemosensitization was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay.	thiazolyl blue	54-114	tumor necrosis factor	Homo sapiens	4-7	
31966695-5	2017	Pretreatment with AUDA (0.5-8 microM) dose-dependently inhibited TNF-alpha-induced proliferation of HASMCs as revealed by the MTT assay and the decreased expression of Cyclin D1 and beta-tubulin.	thiazolyl blue	126-129	tumor necrosis factor	Homo sapiens	65-74	
17454250-4	2007	MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability decreased significantly (p < .05) from 0.00005 to 0.05 mg/ml after 24 h. The proinflammatory mediators of inflammation cytokines interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-alpha, IL-10, and IL-1beta were also assessed.	thiazolyl blue	5-65	tumor necrosis factor	Homo sapiens	240-273	
17764703-1	2007	When cardiomyocytes were subjected to hypoxia, tumor necrosis factor-alpha (TNF-alpha; 3-50 ng/ml) or adenosine (1-100 microM), decreased hypoxic damage as was detected by lactate dehydrogenase (LDH) release, MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) absorbance, ROS (reactive oxygen species) measurement or desmin immunostaining.	thiazolyl blue	214-274	tumor necrosis factor	Homo sapiens	47-74	
17764703-1	2007	When cardiomyocytes were subjected to hypoxia, tumor necrosis factor-alpha (TNF-alpha; 3-50 ng/ml) or adenosine (1-100 microM), decreased hypoxic damage as was detected by lactate dehydrogenase (LDH) release, MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) absorbance, ROS (reactive oxygen species) measurement or desmin immunostaining.	thiazolyl blue	214-274	tumor necrosis factor	Homo sapiens	76-85	
7519747-2	1994	Low concentrations of TNF (1-100 U/ml) suppressed the growth of SF-188 assessed by cell count, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, and thymidine incorporation assay, but not that of LN-382.	thiazolyl blue	95-156	tumor necrosis factor	Homo sapiens	22-25	
10871651-4	2000	IFN-gamma and increasing doses of TNF-alpha resulted in decreasing viability of trophoblast on uncoated as well as fibronectin-coated dishes, as shown by 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assays, but for each TNF/IFN treatment condition viability on fibronectin was higher (P < 0.001).	thiazolyl blue	154-216	tumor necrosis factor	Homo sapiens	34-43	
8679222-5	1996	In parallel experiments, TNF alpha, rTNF alpha-p55, and htr-9 induced human TSMC proliferation as measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay.	thiazolyl blue	114-175	tumor necrosis factor	Homo sapiens	25-34	
7699497-2	1995	PATIENTS AND METHODS: Tumor necrosis factor (TNF) activity in synovial fluid from 27 patients with temporomandibular disorders (TMDs) was studied using the MTT tetrazolium WEHI 164 clone 13 cell cytotoxicity assay.	thiazolyl blue	156-171	tumor necrosis factor	Homo sapiens	45-48